560 related articles for article (PubMed ID: 28903805)
1. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
Riedl MA; Li HH; Cicardi M; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):462-466. PubMed ID: 28903805
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
Baker JW; Bernstein JA; Harper JR; Relan A; Riedl MA
Allergy Asthma Proc; 2018 Sep; 39(5):359-364. PubMed ID: 29954477
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
Li HH; Reshef A; Baker JW; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):456-461. PubMed ID: 28874235
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
Riedl M
Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
[TBL] [Abstract][Full Text] [Related]
8. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial.
Riedl MA; Hurewitz DS; Levy R; Busse PJ; Fitts D; Kalfus I
Ann Allergy Asthma Immunol; 2012 Jan; 108(1):49-53. PubMed ID: 22192966
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
Valerieva A; Caccia S; Cicardi M
Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
[TBL] [Abstract][Full Text] [Related]
11. Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.
Farkas H; Csuka D; Veszeli N; Zotter Z; Szabó E; Varga L
Allergy Asthma Proc; 2014; 35(3):255-9. PubMed ID: 24801469
[TBL] [Abstract][Full Text] [Related]
12. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
Valerieva A; Staevska MT; Grivcheva-Panovska V; Jesenak M; Kőhalmi KV; Hrubiskova K; Zanichelli A; Bellizzi L; Relan A; Hakl R; Farkas H
World Allergy Organ J; 2021 Apr; 14(4):100535. PubMed ID: 33995818
[TBL] [Abstract][Full Text] [Related]
14. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
Bernstein JA; Tyson C; Relan A; Adams P; Magar R
J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366
[TBL] [Abstract][Full Text] [Related]
15. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR
Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the long-term prevention of hereditary angioedema attacks.
Beard N; Frese M; Smertina E; Mere P; Katelaris C; Mills K
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013403. PubMed ID: 36326435
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
Bork K; Bernstein JA; Machnig T; Craig TJ
J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
[TBL] [Abstract][Full Text] [Related]
18. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
[TBL] [Abstract][Full Text] [Related]
19. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
